NLRP3 and cardiac hypertrophy: The pharmacological inhibition of NLRP3 or NLRP3 knockout reduced myocardial inflammation, fibrosis, myocardial hypertrophy, and cardiac dysfunction (Gan et al., 2018; Willeford et al., 2018; Zhang et al., 2020).